RE:RE:RE:RE:I heard nothing to write home to mother about So, I got an opportunity to watch the entire Webinar last night finally.
I think Raze and Wiz, do a good job of summarizing the presentation in both its content and style (mood?)
I would not characterize this as a good news Webinar...i think they said ultimately little has changed its just delayed. The QAPS portion of the business is the future, and they admitted that the delays were unforseen. He did confirm there were many near term opportunities for this business segment.
The antigen segment is and was as expected...A return to normal from pre-pandemic, with some upside expectations.
....I thought the DxTm portion of the presentation was fairly subdued, and I really believe they do not know. Ultimately, although placing blame is not the purpose of this post, I think they did not account for the about face that governments would do with PCR testing of Covid. With the change in procurement for Ontario, they did not have or present a good view of this component of the business, likely because they do not have one. I think it was strongly hinted that instead of a 4th building, they may make more productive use of that building instead,. at least in the near term. It was notable that they are not producing at all.
If there is any 'good news' in the Webinar, it was Kinlytic....Cameron seemed quite positive on a satisfactory 2023 conclusion to the interminable search for a partner. This is absolutely not priced in.
So, as I stated in an earlier post, it is up to me as an investor to reconcile the facts to my hopes....I am prepared to wait a little longer for this management team to realize the fruits of their labour.
Thank you all